[1]
2009. Use of cDNA microarrays to estimate gene modulation profiles induced by zoledronic acid treatment in androgen-resistant prostate cancer cell line (PC3). Hematology Meeting Reports (formerly Haematologica Reports). 2, 3 (Jun. 2009). DOI:https://doi.org/10.4081/hmr.v2i3.365.